Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barcos

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Leukemia|November 1, 1990
Splenectomy in advanced chronic lymphocytic leukemiaR Thiruvengadam, M Piedmonte, M Barcos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's diseaseK J Propert, J R Anderson, M Barcos, et al.
Annals of Surgical Oncology|May 1, 1994
Primary colorectal non-Hodgkin's lymphomaE Busch, M Rodriguez-Bigas, E Mamounas, et al.
Oncogene|May 1, 1992
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breastE Liu, A Thor, M He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodiesF Matsuno, Y Haruta, M Kondo, et al.
Medical and Pediatric Oncology|January 1, 1979
Idiotype in myeloma terminating in erythroleukemiaM Barcos, S Kim, B K Seon, et al.
Medical and Pediatric Oncology|January 1, 1990
Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin's disease: a CALGB studyP Schulman, K McCarroll, M R Cooper, et al.
Cancer Research|May 15, 1994
Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibodyA Kawata, M Yoshida, M Okazaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group BG P Canellos, G R Petroni, M Barcos, et al.
Revista Espanola De Enfermedades Digestivas|July 28, 2009
Alteration of the renal regulatory hormonal pattern during experimental obstructive jaundiceF J Padillo, A Cruz, I Espejo, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Leukemia|November 1, 1990
Splenectomy in advanced chronic lymphocytic leukemiaR Thiruvengadam, M Piedmonte, M Barcos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's diseaseK J Propert, J R Anderson, M Barcos, et al.
Annals of Surgical Oncology|May 1, 1994
Primary colorectal non-Hodgkin's lymphomaE Busch, M Rodriguez-Bigas, E Mamounas, et al.
Oncogene|May 1, 1992
The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breastE Liu, A Thor, M He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodiesF Matsuno, Y Haruta, M Kondo, et al.
Medical and Pediatric Oncology|January 1, 1979
Idiotype in myeloma terminating in erythroleukemiaM Barcos, S Kim, B K Seon, et al.
Medical and Pediatric Oncology|January 1, 1990
Phase II study of MOPLACE chemotherapy for patients with previously treated Hodgkin's disease: a CALGB studyP Schulman, K McCarroll, M R Cooper, et al.
Cancer Research|May 15, 1994
Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibodyA Kawata, M Yoshida, M Okazaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group BG P Canellos, G R Petroni, M Barcos, et al.
Revista Espanola De Enfermedades Digestivas|July 28, 2009
Alteration of the renal regulatory hormonal pattern during experimental obstructive jaundiceF J Padillo, A Cruz, I Espejo, et al.
Pageof 10